A retrospective analysis of 14 consecutive Chinese patients with unresectable or metastatic alveolar soft part sarcoma treated with sunitinib
Conclusions Sunitinib is effective in locally unresectable or metastatic ASPS with a good safety profile. Neoadjuvant treatment with sunitinib improves the chance of resection for patients with locally advanced ASPS.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research
More News: Bleeding | Drugs & Pharmacology | Investigational New Drugs | Neoadjuvant Therapy | Sarcomas | Skin | Study | Toxicology